Technology is increasingly present in the functions of the traditional doctor, even performing some actions that, until recently, were unthinkable. One of the examples of this is Digital Diagnostics, what is the main objective of this company?

Digital Diagnostics was born in 2010 as IDx through the efforts of its founder and president Dr. Michael Abramoff, a retina ophthalmologist, neuroscientist, and computer engineer who developed a unique, proprietary biomarker-based approach to building algorithms that cognitively perform tasks. complex. These algorithms are integrated into user-friendly systems that can make instantaneous clinical decisions in which the computer is the one who makes the medical decision.

We must say that Digital Diagnostics is the leading healthcare technology company designed to offer an automated diagnosis based on AI systems – Artificial Intelligence, whose main mission is to transform the quality, accessibility and sustainability of healthcare worldwide.

You currently have two autonomous artificial intelligences, what does each of them consist of and how do they work?

That’s right, the Digital Diagnostics platform owns the intellectual property of two key autonomous Artificial Intelligence technologies aimed at democratizing Healthcare.

The genesis of the IDx Company, which has recently been renamed Digital Diagnostics, discovered and obtained the CE Marking in 2013 and in 2018 the FDA authorization for the commercialization of its flagship product, LumineticsCore™ (formerly known as IDx-DR), for detection and diagnosis Automated early diagnosis of Diabetic Retinopathy based on an AI algorithmic system that provides a result with a specificity and sensitivity close to 100%.